Llordés Montserrat, Zurdo Elba, Jaén Ángeles, Vázquez Inmaculada, Pastrana Luís, Miravitlles Marc
a CAP Terrassa Sud. Hospital Universitario Mutua de Terrassa, Universidad de Barcelona , Barcelona , Spain.
b Coordinació projectes recerca, Fundació Docència i Recerca Mutua de Terrassa , Terrassa , Spain.
COPD. 2017 Feb;14(1):43-51. doi: 10.1080/15412555.2016.1239703. Epub 2016 Oct 31.
We developed a questionnaire to detect cases of chronic obstructive pulmonary disease (COPD) and compared its reliability with other strategies. In order to develop the new questionnaire (COPD screening questionnaire from Terrassa [EGARPOC]) we used data from an epidemiological study on the prevalence of COPD in smokers and calculated the odds ratio for each variable showing significance for the diagnosis of COPD on regression analysis. For comparison among questionnaires and the portable spirometer COPD-6, a cross-sectional multicenter study was performed. The study included 407 smokers or ex-smokers over the age of 40 years with no known diagnosis of COPD, who completed the different questionnaires (EGARPOC, Respiratory Health Screening Questionnaire, COPD-population screener and 2 questions) and underwent spirometry with the COPD-6. We determined the sensitivity, specificity, positive and negative predictive values (S, Sp, PPV and NPV, respectively) and the area under the receiver operating characteristic ROC curve (AUC ROC) of all the questionnaires and the different COPD-6 cut-offs. The prevalence of COPD was 26.3%. The EGARPOC questionnaire showed an S of 81.8%, an Sp of 70.6%, and an NPV of 91.8%; 73.3% of individuals were correctly classified, and the AUC ROC was 0.841. On comparing the questionnaires by the Chi-square test, the 2-question questionnaire showed the worst discrimination; while with an optimal cut-off of forced expiratory volume in one 1 second (FEV)/FEV of 0.78, the COPD-6 was significantly better than the questionnaires in the detection of COPD. Using a cut-off of FEV/FEV of 0.78 the COPD-6 was found to be the best screening tool for COPD in primary care compared to the questionnaires tested, which did not show differences among them.
我们编制了一份问卷以检测慢性阻塞性肺疾病(COPD)病例,并将其可靠性与其他方法进行比较。为了编制这份新问卷(来自特拉萨斯的COPD筛查问卷[EGARPOC]),我们使用了一项关于吸烟者中COPD患病率的流行病学研究数据,并计算了回归分析中对COPD诊断具有显著意义的每个变量的比值比。为了比较不同问卷与便携式肺量计COPD - 6,我们进行了一项横断面多中心研究。该研究纳入了407名40岁以上无COPD确诊记录的吸烟者或曾经吸烟者,他们完成了不同问卷(EGARPOC、呼吸健康筛查问卷、COPD人群筛查问卷和2个问题),并使用COPD - 6进行了肺功能测定。我们确定了所有问卷以及不同COPD - 6临界值的敏感性、特异性、阳性和阴性预测值(分别为S、Sp、PPV和NPV)以及受试者工作特征曲线下面积(AUC ROC)。COPD的患病率为26.3%。EGARPOC问卷的敏感性为81.8%,特异性为70.6%,阴性预测值为91.8%;73.3%的个体被正确分类,AUC ROC为0.841。通过卡方检验比较问卷时,2个问题的问卷显示出最差的区分能力;而当1秒用力呼气容积(FEV)/用力肺活量(FVC)的最佳临界值为0.78时,COPD - 6在检测COPD方面明显优于问卷。使用FEV/FVC为0.78的临界值时,与所测试的问卷相比,发现COPD - 6是初级保健中COPD的最佳筛查工具,而这些问卷之间未显示出差异。